Busy times: US FDA accepts Sandoz's biosimilar filgrastim filing
Mailroom and legal staff at Sandoz and Amgen are in for a busy six months after the US FDA agreed to review a biosimilar version of the anti-infective, Neupogen.
Mailroom and legal staff at Sandoz and Amgen are in for a busy six months after the US FDA agreed to review a biosimilar version of the anti-infective, Neupogen.
GSK has submitted an application for the world’s first malaria vaccine to the European Medicines Agency (EMA).
The biopharma services market keeps expanding and “growth prospects look fabulous,” says Thermo Fisher, reporting better than expected sales across its Life Sciences business for the second quarter 2014.
Bristol-Myers Squibb and Ono Pharmaceuticals have expanded their collaboration to jointly develop and commercialise the monoclonal antibody drugs Opdivo and Yervoy.